Dark
Light
System
Institutional Investment Manager
Redmile Group, LLC
Redmile Group, LLC (CIK: 0001425738) incorporated in Delaware, located at One Letterman Drive, San Francisco, CA. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q2)
Portfolio Summary: 54 holdings with a total value of $1,046,928,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 ARRAY BIOPHARMA INC COM 19,150,650 68,176,000 6.51%
2 AMICUS THERAPEUTICS INC 11,106,446 60,641,000 5.79%
3 MEDIVATION INC 929,529 56,051,000 5.35%
4 SEATTLE GENETICS INC 1,381,477 55,825,000 5.33%
5 Atara Biotherapeutics Inc 2,408,970 54,226,000 5.18%
6 PENUMBRA INC COM 863,581 51,383,000 4.91%
7 ENDOLOGIX INC 3,962,753 49,376,000 4.72%
8 CLOVIS ONCOLOGY INC 3,097,850 42,503,000 4.06%
9 MOLINA HEALTHCARE INC 845,360 42,183,000 4.03%
10 INTRA CELLULAR THERAPIES INC COM 971,565 37,716,000 3.60%
11 PORTOLA PHARMACEUTICALS INC 1,466,537 34,610,000 3.31%
12 NEVRO CORP 398,371 29,384,000 2.81%
13 BOSTON SCIENTIFIC CORP 1,230,320 28,753,000 2.75%
14 SPDR SER TR 490,900 26,553,000 2.54%
15 Model N Inc 1,900,659 25,374,000 2.42%
16 BIOMARIN 322,394 25,082,000 2.40%
17 NANOSTRING TECHNOLOGIES INC 1,949,185 24,560,000 2.35%
18 INCYTE 302,307 24,179,000 2.31%
19 BROOKDALE SR LIVING INC 1,545,331 23,860,000 2.28%
20 ALEXION PHARMACEUTIC 202,400 23,632,000 2.26%
21 Heartware International, Inc. 405,497 23,417,000 2.24%
22 WAVE LIFE SCIENCES LTD 1,095,473 22,665,000 2.16%
23 AETNA INC NEW 183,225 22,377,000 2.14%
24 CENTENE CORP DEL 285,143 20,351,000 1.94%
25 PROTHENA CORP PLC 487,406 17,040,000 1.63%
26 SYROS PHARMACEUTICALS INC 946,182 15,058,000 1.44%
27 NEURODERM LTD 821,445 13,348,000 1.27%
28 CHIMERIX INC 3,288,376 12,923,000 1.23%
29 Oxford Immunotec Global PLC 1,428,094 12,853,000 1.23%
30 CHARLES RIV LABS INTL INC 131,606 10,850,000 1.04%
31 Adeptus Health Inc 163,474 8,445,000 0.81%
32 PRESS GANEY HLDGS INC 198,214 7,800,000 0.75%
33 SPECTRANETICS CORP 401,836 7,518,000 0.72%
34 CYTOMX THERAPEUTICS INC COM 733,899 7,497,000 0.72%
35 CONFORMIS INC 1,047,821 7,356,000 0.70%
36 ENVISION HEALTHCARE HLDGS INC 288,918 7,330,000 0.70%
37 PHARMERICA CORP 263,862 6,507,000 0.62%
38 VCA INCORPORATED 94,200 6,369,000 0.61%
39 EHEALTH INC COM 426,242 5,976,000 0.57%
40 IRONWOOD PHARMACEUTICALS INC COM CL A 442,711 5,788,000 0.55%
41 AMERICAN RENAL ASSOCIATES HO COM 149,900 4,343,000 0.41%
42 INVITAE CORP 544,939 4,027,000 0.38%
43 ARRAY BIOPHARMA INC 3 06/01/2020 4,000,000 3,382,000 0.32% PRN
44 ProQR Therapeutics NV 581,638 2,815,000 0.27%
45 FATE THERAPEUTICS INC COM 1,502,180 2,554,000 0.24%
46 Syndax Pharmaceuticals Inc 250,830 2,471,000 0.24%
47 BLUEPRINT MEDICINES CORP COM 28,353 574,000 0.05%
48 AXOVANT SCIENCES LTD 25,000 321,000 0.03%
49 BIOGEN INC 1,229 297,000 0.03%
50 LHC GROUP INC COM 5,000 216,000 0.02%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-16-000039, filed 2016.08.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.